Eye drop trial offers hope of reducing invasive treatment for premature babies
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Gothenburg – In a randomized study, repeated topical application of dexamethasone numerically reduced the number of premature infants requiring invasive therapy for progressive retinopathy. However, due to the small number of participants, the therapeutic benefit could not be definitively established. The results were...
Eye drop trial offers hope of reducing invasive treatment for premature babies
Among infants treated with dexamethasone, 20% progressed to treatment-requiring ROP compared with 38% in the placebo group. Image: Toshi Photography/stock.adobe.com.Corticosteroid eyedrops could reduce the need for invasive treatment for retinopathy of prematurity (ROP), according to the world’s first randomised clinical trial investigating the approach. Published in JAMA Pediatrics on 3 August 2026, the trial found dexamethasone eye drops nearl…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
